Physician profile
Adil Habib
NPI 1831119882
$4,671.82
in general payments reported to CMS, 2019-2025
21 companies · $929 in 2025
The $929 reported for 2025 was more than what a typical Transplant Hepatology provider received nationally (typical 2025 total: $508).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $748 · 2020: $391 · 2021: $510 · 2022: $576 · 2023: $594 · 2024: $924 · 2025: $929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,447.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,530.63 | 2019-2025 | |
| Abbvie INC. | $1,506.67 | 2019-2025 | |
| Intercept Pharmaceuticals, INC. | $410.66 | 2019-2024 | Ocaliva |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $409.02 | 2019-2025 | Xifaxan, Plenvu |
| Madrigal Pharmaceuticals | $341.65 | 2024-2025 | Resmetirom, Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $102.65 | 2020-2025 | Livtencity |
| Mallinckrodt Hospital Products INC. | $56.86 | 2022-2023 | Terlivaz |
| Shire North American Group INC | $42.33 | 2019 | |
| Eisai INC. | $32.55 | 2023-2024 | |
| Fujifilm Healthcare Americas Corporation | $27.71 | 2025 | |
| Sequana Medical US INC. | $24.29 | 2025 | Alfapump System |
| Ipsen Biopharmaceuticals, INC | $23.79 | 2025 | Iqirvo |
| Mirum Pharmaceuticals, INC. | $23.05 | 2025 | Chenodal, Livmarli, Cholbam |
| Genentech USA, INC. | $20.94 | 2022 | |
| Amgen INC. | $20.03 | 2025 | Uplizna |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tetraphase Pharmaceuticals, INC. | $17.67 | 2019 | |
| Siemens Medical Solutions USA, INC. | $17.50 | 2019 | |
| Novo Nordisk INC | $17.28 | 2025 | Wegovy |
| Eton Pharmaceuticals, INC. | $16.82 | 2025 | Betaine Anhydrous, Galzin, Nitisinone |
| Intra-Sana Laboratories | $16.26 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Ethicon US, LLC | $13.46 | 2023 | Neuwave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Habib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.